内分泌治疗无效的前列腺癌和前列腺癌生长因子研究进展
内分泌治疗无效的前列腺癌和前列腺癌生长因子研究进展
出处
《中国肿瘤临床与康复》
2004年第4期373-374,共2页
Chinese Journal of Clinical Oncology and Rehabilitation
参考文献19
-
1Estuccia C,Bologna M,Gravina GL,et al.Osteoblast conditionaed media contain TGF-beta Ⅰ and modalate the migration of prostate tumor cells and their interactions with extracellular matrix components[J].Int J Cancer,1999,81:395-397.
-
2Kwak C,Jeong SJ,Park MS,et al.Prognostic significance of the hadir prostate specific antigen level after hormone therapy for prostate cancer[J].J Urol,2002,168:995-1000.
-
3Atto AJ, Perlamn H, Chen MW, et al.Overexperession of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo[J]. Cancer Res,1995,55:4438-4441.
-
4Hobisch A, Culig Z,Radmayr C,et al.Distant metastases from prostate carcinoma express androgen receptor protein[J].Cancer Res,1995,55:3068-3069.
-
5Viskorpi T, Hyytinen E, Koivisto P,et al.In vivo amplification of the androgen receptor gene and progression of human prostate cancer[J]. Nat Genet,1995,9:401-402.
-
6Truong LD,Kadmon D.Association of transforming growth factor-beta with prostate cancer an immunohistochemical study[J].Human Pathol,1993,4:24-26.
-
7Weidner N,Semple JP.Tumor angiogenesis and metastasis correlation in invasive prostate carcinoma[J]. N Engl J Med,1991,1:324-327.
-
8Nasu Y, Timme TL, Yang G,et al.Suppression of caveolin expression induces androgen sensitivity in metastatic androgen insensitive mouse prostatic cancer cells[J].Nat Med,1998,4:1062-1063.
-
9Steiner MS, Barrack ER.Transforming growth factor-beta I overproduction in prostate cancer: effects on growth in vivo and in vitro[J]. Mol Endocrinol, 1992,6:15-17.
-
10Isaacs JT,Coffey DS.Etiology and disease process of benign prostatic hgperplasia[J].Prostate,1989,2:33-50.
-
1江凤英,吉兆宁.多西他赛联合希罗达及其序贯单药维持治疗晚期乳腺癌的临床观察[J].北方药学,2015,12(4):14-15. 被引量：6
-
2张兆宏,李文广,刘春雨,姚庆祥.前列腺偶发癌9例临床分析[J].华夏医药,2009,4(2):146-148.
-
3方琦,王旭芬.非激素依赖性乳腺癌CerbB-2表达与P53、Ki-67的关系研究[J].南方医科大学学报,2011,31(2):380-382. 被引量：16
-
4王鹏,张延伦,李墨农,邓军,张钢,张晏,王新生,孙立江.血管活性肠肽对非激素依赖性前列腺癌细胞增殖和转移的影响[J].中华实验外科杂志,2015,32(12):2970-2972. 被引量：2
-
5李天庆,王剑松.联合多西紫杉醇治疗非激素依赖性前列腺癌临床进展[J].中华男科学杂志,2008,14(3):264-267. 被引量：5
-
6丁建业,吴志坚,王进峰,李小刚,陈第荣,陈善群.前列腺癌内分泌治疗前后血PSA变化的临床意义[J].医学临床研究,2007,24(8):1307-1308. 被引量：5
-
7王加强,孙文涛,王孟春.晚期前列腺癌的内分泌治疗[J].中华临床医药杂志（北京）,2004,5(19):25-26.
-
8杨建安,王斌,秦自科,李靖.晚期前列腺癌患者行间歇性内分泌治疗的疗效分析[J].中华腔镜泌尿外科杂志（电子版）,2014,8(1):42-46. 被引量：9
-
9陈江,陈晓春,曾甫清.TRAIL抑制人前列腺癌细胞PC-3M体外生长的实验研究[J].肿瘤防治研究,2004,31(7):395-397. 被引量：3
-
10刘丁,陈新石.非那雄胺的新作用:预防前列腺癌?[J].中华医学杂志,2003,83(15):1349-1349. 被引量：5
